1-19 of 19
Ali Alahmari
Close
Save search
Sort by
Journal Articles

Significant Growth in HCT Use for Haemoglobinopathies in the Last Decade Driven By Sickle Cell Disease across All Ages with Excellent Outcomes: An Analysis of EBMT Haemoglobinopathies Working Party

Free
Josu de la Fuente, Jacques-Emanuel Galimard, Arnaud Dalissier, Mohsen Al Zahrani, Ali Alahmari, Ashrafsadat Mousavi, Javid Gaziev, Akif Yesilipek, Khalid Halahleh, Franco Locatelli, Gulyuz Ozturk, Bulent Antmen, Mahmoud Aljurf, Jean-Hugues Dalle, Arjan C. Lankester, Marco Zecca, O. Alphan Kupesiz, Sandrine Bremathas, Selim Corbacioglu, Emanuele Angelucci
Journal: Blood
Blood (2024) 144 (Supplement 1): 2184.
https://doi.org/10.1182/blood-2024-208191
Published: 2024
Journal Articles

Allogeneic Transplantation for Sickle Cell Disease Offers High Rates of Cure with Low Incidence of Severe Chronic GVHD in Both Children and Adults: Real World Data from 2010-2021. An Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party

Free
Josu de la Fuente, Jacques-Emanuel Galimard, Arnaud Dalissier, Mohsen Al Zahrani, Ali Alahmari, Fahad Almohareb, Jean-Hugues Dalle, Nathalie Dhédin, Hakan Ozdogu, Mohamed Salaheldin Bayoumy, Marco Zecca, Cristina Belendez, Javid Gaziev, Arjan C. Lankester, Philippe Lewalle, Sr., Gaurav Kharya, Sarah Lawson, Bénédicte Neven, Sandrine Bremathas, Emanuele Angelucci
Journal: Blood
Blood (2024) 144 (Supplement 1): 176.
https://doi.org/10.1182/blood-2024-207944
Published: 2024
Journal Articles

Steroid Pre-Busulfan Based Reduced-Intensity Conditioning in Matched Related Hematopoietic Stem Cell Transplantation: Outcomes in Young and Adult Sickle Cell Disease Patients

Free
Abdulrahman Nasiri, Sarah Samarkandi, Reem Alasbali, Ahmed Alahmadi, Marwa Nassar, Huda Alfattah, Yousef Bukhari, Anas Fallatah, Hadeel Samarkandi, Tariq Alzahrani, Haya Alothaimeen, Tusneem Ahmed M Elhassan, Fahad Alotaibi, Ahmed Kotb Abdrabou, Alfadil Haroon, Mostafa Saleh, Riad Elfakih, Saud Alhayli, Amr Hanbali, Feras Abdulaziz Alfraih, Walid Rasheed, Syed Osman Ahmed, Naeem A. Chaudhri, Ahmad S. Alotaibi, Said Yousuf Ahmed, Hazza Alzahrani, Mahmoud Aljurf, Fahad Almohareb, Ali Alahmari
Journal: Blood
Blood (2024) 144 (Supplement 1): 1142.
https://doi.org/10.1182/blood-2024-200303
Published: 2024
Journal Articles

Favorable Outcomes with Bridging Radiation Therapy Prior to Anti-CD19 Chimeric Antigen Receptor T-Cell CART in B Cell Lymphoma, a Report from Saudi Arabia

Free
Amal Hejab, Khalid Alsuhaibani, Syed Osman Ahmed, Yasser Khafaga, Mohamed Alshabanah, Ali Alahmari, Amr Hanbali, Walid Rasheed, Alfadel Alshaibani, Naeem A. Chaudhri, Ayman Saad, Shaykhah Alotaibi, Hanan Alkhaldi, Abdullah Alamer, Mansour Alfayez, Saud Alhayli, Hadeel H Samarkandi, Tusneem Ahmed M Elhassan, Farhatullah Syed, Marwan Shaheen, Feras Abdulaziz Alfraih, Ahmad S. Alotaibi, Fahad Alsharif, Fahad Almohareb, Hazza A. Alzahrani, Mahmoud Aljurf, Riad Elfakih, Abdulwahab Albabtain
Journal: Blood
Blood (2024) 144 (Supplement 1): 7754.
https://doi.org/10.1182/blood-2024-202399
Published: 2024
Journal Articles

Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Patients Receiving Inotuzumab Ozogamicin Followed By Total Body Irradiation-Based Conditioning for Stem Cell Transplantation: A Risk Mitigation Strategy

Free
Ahmed Alahmadi, Abdulrahman Nasiri, Sarah Samarkandi, Haya Alothaimeen, Marwa Nassar, Ali Alahmari, Ahmad S. Alotaibi, Mansour Alfayez, Hanan Alkhaldi, Ayman Saad, Syed Osman Ahmed, Amr Hanbali
Journal: Blood
Blood (2024) 144 (Supplement 1): 7306.
https://doi.org/10.1182/blood-2024-200803
Published: 2024
Journal Articles

Non-Western Real-World Experience of Axi-Cel CAR-T in Refractory/Relapsed B-Cell Lymphoma from a Tertiary Center in Saudi Arabia

Free
Khalid Alsuhaibani, Amal Hejab, Syed Osman Ahmed, Ali Alahmari, Amr Hanbali, Walid Rasheed, Alfadel Alshaibani, Naeem A. Chaudhri, Ayman Saad, Shaykhah Alotaibi, Hanan Alkhaldi, Abdullah Alamer, Mansour Alfayez, Saud Alhayli, Marwan Shaheen, Feras Abdulaziz Alfraih, Ahmad S. Alotaibi, Hadeel Samarkandi, Farhatullah Syed, Fahad Alsharif, Fahad Almohareb, Hazza Alzahrani, Mahmoud Aljurf, Riad Elfakih, Abdulwahab Albabtain
Journal: Blood
Blood (2024) 144 (Supplement 1): 7824.
https://doi.org/10.1182/blood-2024-203769
Published: 2024
Journal Articles

Age Is a Crucial Determinant of GFRS with Incidence of Severe Chronic GVHD Reducing over Time in Haemopoietic Cell Transplantation for Transfusion Dependent Thalassaemia: Real World Data from 2010-2021. an Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party

Free
Donatella Baronciani, Josu de la Fuente, Jacques-Emanuel Galimard, Arnaud Dalissier, Ashrafsadat Mousavi, Akif Yesilipek, Hasan Hashem, Gulyuz Ozturk, Franco Locatelli, Ali Alahmari, Javid Gaziev, Ali Bülent Antmen, O. Alphan Kupesiz, Tunc Fisgin, Giorgio La Nasa, Arjan C. Lankester, Eugene Goussetis, Sandrine Bremathas, Emanuele Angelucci
Journal: Blood
Blood (2024) 144 (Supplement 1): 2136.
https://doi.org/10.1182/blood-2024-208421
Published: 2024
Journal Articles

Evaluating the Safety and Efficacy of Tyrosine Kinase Inhibitors in Pregnant Patients with Chronic Myeloid Leukemia: A Comprehensive 15-Year Single-Center Study

Free
Nourah Alzaidy, Chokri Ben Lamine, Mohamed Isam Sharif, Amal Hejab, Marwan Shaheen, Feras Abdulaziz Alfraih, Fahad Z. Alsharif, Ayman Saad, Amr Hanbali, Riad Elfakih, Marwa Nassar, Sarah Samarkandi, Haya Alothaimeen, Maha Abdullah Hassan, Balqees Alzayed, Saud Alhayli, Ali Alahmari, Alfadel Alshaibani, Ahmad S. Alotaibi, Abdullah Alamer, Hanan Alkhaldi, Shaykhah Alotaibi, Mansour Alfayez, Abdulwahab Albabtain, Syed Osman Ahmed, Walid Rasheed, Hazza Alzahrani, Fahad Almohareb, Mahmoud Aljurf, Naeem A. Chaudhri
Journal: Blood
Blood (2024) 144 (Supplement 1): 4536.
https://doi.org/10.1182/blood-2024-207937
Published: 2024
Journal Articles

Prognostic Impact of CD19 Status Pre-Lymphodepletion in Anti-CD19 CAR-T Therapy for B-Acute Lymphoblastic Leukemia

Free
Nourah Alzaidy, Mostafa Faisal Mohammed Saleh, Ahmed Abdrabou, Reem Alasbali, Amer Bugnah, Taimor Hussain, Haroon Alfadhil, Ahmed Bin salman, Momen Nassani, Yazeed Bajuaifer, Mohamed Isam Sharif, Marwa Nassar, Sarah Samarkandi, Heba Madien, Amal Hejab, Samar Alfaqawi, Shihab Ahmed, Chokri Benlamine, Shaykhah Alotaibi, Hanan Alkhaldi, Abdullah Alamer, Ayman Saad, Ahmed Alotaibi, Walid Rasheed, Marwan Shaheen, Alfadel Alshaibani, Saud Alhayli, Mansour Alfayez, Abdulwahab Albabtain, Riad Elfakih, Feras Abdulaziz Alfraih, Amr Hanbali, Fahad Alsharif, Naeem A. Chaudhri, Hazza Alzahrani, Fahad Almohareb, Syed Osman Ahmed, Mahmoud Aljurf, Ali Alahmari
Journal: Blood
Blood (2024) 144 (Supplement 1): 7153.
https://doi.org/10.1182/blood-2024-207988
Published: 2024
Journal Articles

Real World Data of Glofitamab in Relapsed Refractory Large B-Cell Lymphoma in Non-Western Population from a Tertiary Center in Saudi Arabia

Free
Rashed B. Albakr, Noha Barradah, Walid Rasheed, Riad O. El Fakih, Alfadel Alshaibani, Saud Alhayli, Ali Alahmari, Naeem A. Chaudhri, Abdullah Alamer, Yazeed M AlDalilah, Ahmed A AlRuwaili, Riyadh I AlSalloum, Abdulaziz S AlSugair, Hadeel H Samarkandi, Tusneem Ahmed M Elhassan, Mahmoud Aljurf, Abdulwahab Albabtain
Journal: Blood
Blood (2024) 144 (Supplement 1): 7773.
https://doi.org/10.1182/blood-2024-198772
Published: 2024
Journal Articles

Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Free
Manar Aleid, Abdullah Alrajhi, Mohammmad Alwadi, Ali Alsugair, Hassan Alshehri, Imran K Tailor, Amr Hanbali, Feras Abdulaziz Alfraih, Saud Alhayli, Ali Alahmari, Abdulwahab Albabtain, Ahmad S. Alotaibi, Mohammed S Alnoamani, Nawal F Alshehry, Ibraheem H Motabi, Hazza A Alzahrani, Mohammed A Marei, Ayman Saad, Mahmoud Aljurf, Riad Elfakih, Muhned Alhumaid, Mansour Alfayez
Journal: Blood
Blood (2023) 142 (Supplement 1): 5889.
https://doi.org/10.1182/blood-2023-180221
Published: 2023
Journal Articles

Utility and Validity of Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Predicting Overall Survival and Non-Relapse Mortality in Adolescent and Young Adult Population

Free
Ali Alsugair, Syed O. Ahmed, Mohamed Isam Sharif, Tusneem Elhassan, Hazza A. Alzahrani, Fahed Almhareb, Naeem A. Chaudhri, Fahad Alsharif, Walid Rasheed, Amr Hanbali, Feras Abdulaziz Alfraih, Marwan Shaheen, Riad El Fakih, Saud Alhayli, Ali Alahmari, Alfadel Alshaibani, Abdulwahab Albabtain, Ahmad S. Alotaibi, Mansour Alfayez, Mahmoud Aljurf
Journal: Blood
Blood (2022) 140 (Supplement 1): 10566–10567.
https://doi.org/10.1182/blood-2022-167509
Published: 2022
Journal Articles

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Free
Adetola A. Kassim, Karina Wilkerson, Josu de la Fuente, Adriana Seber, Roseane V Gouveia, Carmem Bonfim, Belinda Pinto Simões, Erfan Nur, Biljana N. Horn, Michael Eckrich, Rabi Hanna, Nathalie Dhedin, Fahed Almhareb, Mahmoud Aljurf, Hemalatha G. Rangarajan, Katie S. Gatwood, James P Connelly, Mohsen Alzahrani, Ali Alahmari, Mark Rodeghier, Michael R. DeBaun
Journal: Blood
Blood (2022) 140 (Supplement 1): 2383–2385.
https://doi.org/10.1182/blood-2022-165229
Published: 2022
Journal Articles

Successful Restoration of Nivolumab Efficacy Post Allogeneic Stem Cell Transplantation in Hodgkin's Lymphoma

Free
Khawlah Farhan, Abdulwahab Albabtain, Saud Alhayli, Walid Rasheed, Alfadel Alshaibani, Naeem A. Chaudhri, Ali Alahmari, Mahmoud Aljurf, Riad El Fakih
Journal: Blood
Blood (2022) 140 (Supplement 1): 12048–12049.
https://doi.org/10.1182/blood-2022-158953
Published: 2022
Journal Articles

Allogeneic Hematopoietic Cell Transplant Yields Long Term Disease Free Survival in a Significant Number of Patients with Classic Hodgkin Lymphoma

Free
Ahmed Bin Salman, Syed O. Ahmed, Saleha abdul Rab, Hiba Raheel, Areez Shafqat, Saud Alhayli, Alfadel Alshaibani, Naeem A. Chaudhri, Abdulwahab Albabtain, Feras Abdulaziz Alfraih, Mansour Alfayez, Fahad Alsharif, Marwan Shaheen, Amr Suleiman Hanbali, Ahmad S. Alotaibi, Walid Rasheed, Fahed Almhareb, Ali Alahmari, Hazza Alzahrani, Mahmoud Aljurf, Riad El Fakih
Journal: Blood
Blood (2022) 140 (Supplement 1): 12969–12970.
https://doi.org/10.1182/blood-2022-164820
Published: 2022
Journal Articles

Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients : A Single Center Analysis of 97 Patients

Free
Afnan Al-Sabbagh, Hazza Alzahrani, Majed J. Dasouki, Taimoor Hussain, Ayodele Alaiya, Ali Alahmari, Emad Ghabashi, Raghad Al Ammari, Abdullah Faruk Demirkaya, Moheeb Alawwami, Naeem A. Chaudhri, Fahad Alsharif, Walid Rasheed, Amr Hanbali, Marwan Shaheen, Feras Abdulaziz Alfraih, Riad Elfakih, Shahrukh K. Hashmi, Saud Alhayli, Ahmad S. Alotaibi, Alfadel Alshaibani, Abdulwahab Albabtain, Shaykhah Alotaibi, Mostafa Saleh, Ahmed Abdrabou, Ahmed Bin salman, Haroon Alfadhil, Ahmed Al Sagheir, Riad Youniss, Manju Abraham, Bandar Alotaibi, Sahar Ramadan, Ahmad Alhuraiji, Almohareb Fahad, Mahmoud Aljurf, Syed O. Ahmed
Journal: Blood
Blood (2022) 140 (Supplement 1): 11471–11473.
https://doi.org/10.1182/blood-2022-162734
Published: 2022
Journal Articles

Sequential Fludarabine, Ara-C, Etoposide (FLAV) Followed By Fludarabine/ Busulfan Reduced Toxicity Conditioning Is Safe and Effective Salvage for Adult Patients with Refractory Acute Myeloid Leukemia and High Risk Myelodysplasia

Free
Ahmad S. Alotaibi, Shad Ahmed, Walid Rasheed, Marwan Shaheen, Nadiah Alobaidi, Ahmad Alnughmush, Amal Hejab, Taimoor Hussain, Ahmed Abdrabou, Haroon Alfadhil, Mostafa Saleh, Ahmed Bin Salman, Majed Altareb, Momen Nassani, Yazeed S Bajuaifer, Mohamed Isam Sharif, Emad Ghabashi, Shaykhah Alotaibi, Riad Youniss, Alfadel Alshaibani, Ali Alahmari, Saud Alhayli, Riad Elfakih, Feras Al Fraih, Amr Suleiman Hanbali, Fahad Alsharif, Naeem A. Chaudhri, Hazza Alzahrani, Fahed Almhareb, Mahmoud Aljurf, Syed O. Ahmed
Journal: Blood
Blood (2021) 138 (Supplement 1): 1851.
https://doi.org/10.1182/blood-2021-152602
Published: 2021
Journal Articles

Dasatinib Induced Reversible Nephrotic Range Proteinuria Occurs More Frequently Compared to Other Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Free
Ali Alahmari, MD, Jeffrey H. Lipton, MD PhD, Dennis Kim, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2880.
https://doi.org/10.1182/blood.V130.Suppl_1.2880.2880
Published: 2017
Journal Articles

Improved Molecular Diagnosis of Aplastic Anemia/Bone Marrow Failure Syndromes Using a Novel Comprehensive Next Generation Sequencing Gene Panel

Free
Majed Dasouki, MD, DABMG, Syed Osman Ahmed, MRCP, FRCPath, Ali Alahmari, MD, Amal Jabr, BSc, Moheeb Ali Alawwami, MSc, PhD, Naeem A. Chaudhri, MD FACP, AlMohareb Fahad, MD, Said Y Mohamed, MD, Walid Rasheed, MD, Hazza A Alzahrani, MD, Mahmoud Aljurf, MD MPH
Journal: Blood
Blood (2015) 126 (23): 4790.
https://doi.org/10.1182/blood.V126.23.4790.4790
Published: 2015